CN110691611A - 多价疫苗组合物 - Google Patents

多价疫苗组合物 Download PDF

Info

Publication number
CN110691611A
CN110691611A CN201780052380.5A CN201780052380A CN110691611A CN 110691611 A CN110691611 A CN 110691611A CN 201780052380 A CN201780052380 A CN 201780052380A CN 110691611 A CN110691611 A CN 110691611A
Authority
CN
China
Prior art keywords
present
amount
type
antigen
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780052380.5A
Other languages
English (en)
Chinese (zh)
Inventor
R·M·迪尔
S·S·皮索尔
J·K·扎德
R·N·沙伯尔
R·B·卡达姆
A·S·卡姆伯
江保明
R·格拉斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serum Institute of India Pvt Ltd
US Department of Health and Human Services
Original Assignee
Serum Institute of India Pvt Ltd
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serum Institute of India Pvt Ltd, US Department of Health and Human Services filed Critical Serum Institute of India Pvt Ltd
Publication of CN110691611A publication Critical patent/CN110691611A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CN201780052380.5A 2016-08-26 2017-08-24 多价疫苗组合物 Pending CN110691611A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201621029037 2016-08-26
IN201621029037 2016-08-26
PCT/IB2017/055100 WO2018037365A1 (en) 2016-08-26 2017-08-24 Multivalent vaccine composition

Publications (1)

Publication Number Publication Date
CN110691611A true CN110691611A (zh) 2020-01-14

Family

ID=60083359

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780052380.5A Pending CN110691611A (zh) 2016-08-26 2017-08-24 多价疫苗组合物

Country Status (17)

Country Link
US (1) US11235054B2 (https=)
EP (1) EP3503917B1 (https=)
JP (3) JP7384667B2 (https=)
KR (1) KR102607295B1 (https=)
CN (1) CN110691611A (https=)
AU (1) AU2017316768B2 (https=)
CA (1) CA3032901A1 (https=)
CU (1) CU24682B1 (https=)
EA (1) EA201900117A1 (https=)
IL (1) IL264605B2 (https=)
MX (1) MX2019001780A (https=)
MY (1) MY191163A (https=)
PE (1) PE20200004A1 (https=)
PH (1) PH12019500404B1 (https=)
SG (1) SG11201900365WA (https=)
UA (1) UA129115C2 (https=)
WO (1) WO2018037365A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2776196C1 (ru) * 2021-08-24 2022-07-14 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Штамм вируса гриппа ИнфлюБакт-H7/PspA для производства комбинированной вакцины против вируса гриппа А и бактериальной пневмонии, вызываемой Streptococcus pneumoniae

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201900365WA (en) * 2016-08-26 2019-02-27 Serum Institute Of India Pvt Ltd Multivalent vaccine composition
US11793873B2 (en) 2017-05-10 2023-10-24 University Of Massachusetts Bivalent dengue/hepatitis B vaccines
MX2021004233A (es) * 2018-10-12 2021-08-16 Serum Inst Of India Private Ltd Composicion de vacuna combinada que comprende dosis reducidas del virus inactivado de la polio y metodo de preparacion de la misma.
JOP20200214A1 (ar) 2019-09-03 2021-03-03 Serum Institute Of India Pvt Ltd تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008028956A1 (en) * 2006-09-07 2008-03-13 Glaxosmithkline Biologicals S.A. Vaccine
CN102196817A (zh) * 2008-10-24 2011-09-21 万能药生物有限公司 具有全细胞百日咳的联合疫苗
CN102695522A (zh) * 2009-05-12 2012-09-26 美国政府(由卫生和人类服务部、疾病控制和预防中心的部长所代表) 新的人轮状病毒株和疫苗
CN103442730A (zh) * 2011-01-05 2013-12-11 巴拉特生物技术国际有限公司 组合七价疫苗
WO2016063291A1 (en) * 2014-10-07 2016-04-28 Serum Institute Of India Private Limited Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008536515A (ja) 2005-04-18 2008-09-11 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド ワクチンの調製のためのｂ型肝炎ウイルス表面抗原の発現
WO2012117377A1 (en) * 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
SG11201900365WA (en) * 2016-08-26 2019-02-27 Serum Institute Of India Pvt Ltd Multivalent vaccine composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008028956A1 (en) * 2006-09-07 2008-03-13 Glaxosmithkline Biologicals S.A. Vaccine
CN102196817A (zh) * 2008-10-24 2011-09-21 万能药生物有限公司 具有全细胞百日咳的联合疫苗
CN102695522A (zh) * 2009-05-12 2012-09-26 美国政府(由卫生和人类服务部、疾病控制和预防中心的部长所代表) 新的人轮状病毒株和疫苗
CN103442730A (zh) * 2011-01-05 2013-12-11 巴拉特生物技术国际有限公司 组合七价疫苗
WO2016063291A1 (en) * 2014-10-07 2016-04-28 Serum Institute Of India Private Limited Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAOMING JIANG等: "Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity?", 《HUMAN VACCINES & IMMUNOTHERAPEUTICS》 *
BAOMING JIANG等: "Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity?", 《HUMAN VACCINES & IMMUNOTHERAPEUTICS》, vol. 9, no. 8, 8 August 2013 (2013-08-08), pages 1 - 4, XP055430376, DOI: 10.4161/hv.24958 *
M GAUTAM等: "Immune response modulation to DPT vaccine by aqueous extract of Withania somnifera in experimental system", INTERNATIONAL IMMUNOPHARMACOLOGY, vol. 4, no. 6, pages 841 - 849 *
PRASHANT BAGHERWAL等: "Immune Response modulation to DPT (Diphtheria, Pertussis, Tetanus) vaccine by NDL from Calotropis Procera", INTERNATIONAL JOURNAL OF PHARMA AND BIO SCIENCES, vol. 4, no. 2, pages 852 - 859 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2776196C1 (ru) * 2021-08-24 2022-07-14 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Штамм вируса гриппа ИнфлюБакт-H7/PspA для производства комбинированной вакцины против вируса гриппа А и бактериальной пневмонии, вызываемой Streptococcus pneumoniae

Also Published As

Publication number Publication date
MX2019001780A (es) 2020-01-13
PH12019500404A1 (en) 2020-01-20
PH12019500404B1 (en) 2024-05-15
AU2017316768B2 (en) 2024-04-11
JP2021181445A (ja) 2021-11-25
EA201900117A1 (ru) 2019-09-30
BR112019003419A2 (pt) 2019-05-21
AU2017316768A1 (en) 2019-04-11
NZ751127A (en) 2025-08-29
EP3503917B1 (en) 2024-07-03
IL264605B2 (en) 2023-04-01
US11235054B2 (en) 2022-02-01
US20190175722A1 (en) 2019-06-13
WO2018037365A1 (en) 2018-03-01
CU20190013A7 (es) 2019-10-04
JP2024009899A (ja) 2024-01-23
KR20190142311A (ko) 2019-12-26
SG11201900365WA (en) 2019-02-27
UA129115C2 (uk) 2025-01-22
IL264605B (en) 2022-12-01
IL264605A (en) 2019-02-28
CU24682B1 (es) 2023-10-06
EP3503917A1 (en) 2019-07-03
MY191163A (en) 2022-06-03
PE20200004A1 (es) 2020-01-06
JP2019526635A (ja) 2019-09-19
JP7384667B2 (ja) 2023-11-21
WO2018037365A8 (en) 2018-09-20
CA3032901A1 (en) 2018-03-01
KR102607295B1 (ko) 2023-11-29

Similar Documents

Publication Publication Date Title
TWI786153B (zh) 具有改善之安定性、增強之免疫原性及降低之反應原性的免疫原性組成物和其製備方法
JP2024009899A (ja) 多価ワクチン組成物
CN103442730B (zh) 组合七价疫苗
CA2685506A1 (en) Vaccine
JP2012506421A (ja) 新規な無細胞百日咳ワクチン組成物およびその製造方法
CA2963897C (en) Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
CN102196817B (zh) 具有全细胞百日咳的联合疫苗
EP3863665A1 (en) Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same
TW202038995A (zh) 多價疫苗組合物
CA2769011C (en) Vaccine stabilizer
US11793869B2 (en) Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
EA043682B1 (ru) Комбинированная вакцина и способ её производства (варианты)
BR112019003419B1 (pt) Vacina combinada e processo de fabricação de uma vacina combinada
OA20569A (en) Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof.
OA21991A (en) Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof.
OA18258A (en) Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200114